The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 28th 2024
Researchers developed a method to stabilize respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) fusion (F) proteins, advancing potential vaccines for both viruses.
Independent Corner: Interacting with Health Systems
August 22nd 2019Community Pharmacy Consultant Bruce Kneeland speaks with Kevin DeMass, RPh, President of Apothecary Shoppe, Salt Lake City, UT, discusses how the pharmacy staff interacts with physicians, health care providers, and payers on a daily basis.
Watch
FDA Issues Warning Letter to OTC Drug Manufacturer For Data Integrity Concerns
August 21st 2019The FDA has published a warning letter sent to Ningbo Huize Commodity, an over-the-counter drug manufacturer, citing significant current good manufacturing practice (CGMP) violations including data integrity issues.
Read More
Survey: Customer Satisfaction With Pharmacists Remain High
August 21st 2019Despite e-commerce disruptions to the industry, a recent study found that the United States pharmacy industry continues to maintain high levels of customer satisfaction in both the brick-and-mortar and mail order segments.
Read More
New Treatment for Rheumatoid Arthritis Granted FDA Approval
August 19th 2019Officials with the FDA have approved AbbVie’s upadacitinib (Rinvoq) 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate (MTX-IR).
Read More
August 16 Week in Review: Noninvasive Bladder Cancer Test; Mental Health Genetic Testing Services
August 16th 2019This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Watch
FDA Approves Fenofibrate Product for Treating Certain Cholesterol Conditions
August 14th 2019Officials with the FDA have approved Alembic Pharmaceuticals’ Fenofibrate Tablets USP, 48 mg and 145 mg as an adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), Triglycerides and apolipoprotein B (Apo B).
Read More
Genomind Expands Mental Health Genetic Testing
August 13th 2019Genomind is expanding its mental health genetic testing services with the addition of Genomind Professional PGx Express, which provides a more focused report and set of services to enhance the preexisting mental health genetic test.
Read More